Chemical & Engineering News: Latest News

Macular degeneration-focused firm eyes the clinic after series B

Character Biosciences raises $93 million to advance its peptide-based eye disease treatments

Mar 26, 2025 - 14:14
 0
Macular degeneration-focused firm eyes the clinic after series B
Character Biosciences raises $93 million to advance its peptide-based eye disease treatments
Read More

Tags:

Previous Article

Stephen Curry teams up with Michelle Obama to launch sports drink

Next Article

NK Motors opens used car showroom 25 years after acquisition

Related Posts

The ‘compuchem’-AI showdown

The ‘compuchem’-AI showdown

Feb 9, 2025  0

How the bone marrow microbiome responds to immunotherapy

How the bone marrow microbiome responds to immunotherapy

Feb 9, 2025  0

FDA approves new nonopioid pain medication, hailed a 'triumph'

FDA approves new nonopioid pain medication, hailed a &#...

Feb 9, 2025  0